Veeva Systems Boosts MedTech Clinical Trial Efficiency with Cloud Solutions
- Over 50 medical technology companies, including top firms, adopt Veeva's Clinical Platform for improved trial efficiency.
- Veeva's solutions reduce study build times by 50% and duplicate documents by 80%, enhancing compliance and operations.
- Veeva Systems supports over 1,000 life sciences customers, driving innovation in clinical trials for the medtech industry.
Veeva Systems Enhances Clinical Trial Efficiency for MedTech Industry
Veeva Systems, a leader in cloud software solutions for life sciences, announces a significant milestone as over 50 medical technology companies, including 11 of the top 20 firms and seven of the ten leading clinical research organizations (CROs), adopt its Clinical Platform applications. This shift comes in response to increased regulatory demands and the evolving landscape of the medtech industry. By transitioning from outdated legacy systems to Veeva's modern, interconnected solutions, these companies are able to enhance the efficiency and speed of their clinical studies for medical devices and diagnostics.
The adoption of Veeva’s Clinical applications brings notable improvements in trial management. Companies utilizing Veeva's Electronic Data Capture (EDC) report a staggering 50% reduction in study build times, while the Electronic Trial Master File (eTMF) significantly cuts down on duplicate trial documents by 80%. These advancements not only streamline operations but also ensure compliance with local, regional, and global regulations. Kevin Liang, Vice President of Clinical Strategy at Veeva MedTech, expresses enthusiasm about collaborating with the industry to create a connected infrastructure that facilitates faster delivery of life-changing products to patients.
Feedback from industry leaders underscores the effectiveness of Veeva's platform. Leianne Ebert from Alcon notes a 50% improvement in the standardization of clinical data operations within a year, while Kimberly Dorsch of LifeNet Health highlights the platform’s capability to consistently collect compliant study data across various trial types. Furthermore, Matt Christensen from Smith+Nephew reports a remarkable 90% reduction in quality control time after implementing Veeva's eTMF. As Veeva Systems continues to support over 1,000 customers in the life sciences sector, its commitment to innovation and customer success remains a driving force behind its growth and influence in the medtech landscape.
Beyond its impressive adoption rates, Veeva Systems is poised to play a pivotal role in the future of clinical trials in the medical technology sector. Companies are increasingly recognizing the need for modern solutions that meet the complexities of today’s regulatory environment and market dynamics. As the medtech industry undergoes a digital transformation, Veeva's Clinical Platform applications are becoming essential tools for organizations aiming to enhance trial efficiency and ultimately improve patient access to innovative medical technologies. For more information on Veeva's offerings for the medtech sector, interested parties are encouraged to visit veeva.com/MedTechClinical.